The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
2002/12/01 by Patrick E. MacDonald, Wasim El-kholy, Michael Riedel +5 · 28 citations
Medicine · Neuroscience · #Diabetes Treatment and Management #Pancreatic function and diabetes #Neuropeptides and Animal Physiology
paper · doi:10.2337/diabetes.51.2007.s434
Abstract
The physiological effects of glucagon-like peptide-1 (GLP-1) are of immense interest because of the potential clinical relevance of this peptide. Produced in intestinal L-cells through posttranslational processing of the proglucagon gene, GLP-1 is released from the gut in response to nutrient ingestion. Peripherally, GLP-1 is known to affect gut motility, inhibit gastric acid secretion, and inhibit glucagon secretion. In the central nervous system, GLP-1 induces satiety, leading to reduced weight gain. In the pancreas, GLP-1 is now known to induce expansion of insulin-secreting beta-cell mass, in addition to its most well-characterized effect: the augmentation of glucose-stimulated insulin secretion. GLP-1 is believed to enhance insulin secretion through mechanisms involving the regulation of ion channels (including ATP-sensitive K(+) channels, voltage-dependent Ca(2+) channels, voltage-dependent K(+) channels, and nonselective cation channels) and by the regulation of intracellular energy homeostasis and exocytosis. The present article will focus principally on the mechanisms proposed to underlie the glucose dependence of GLP-1's insulinotropic effect.
Cited by
- A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk
- Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly
- Progesterone sulfates are enterohepatically recycled and stimulate G protein-coupled bile acid receptor 1-mediated gut hormone release
- Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy. [europepmc]
- Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. [europepmc]
- Lipotoxicity disrupts incretin-regulated human β cell connectivity. [europepmc]
- Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S. [europepmc]
- Suppression of insulin production and secretion by a decretin hormone. [europepmc]
- Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study. [europepmc]
- Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. [europepmc]
- Capsaicin in Metabolic Syndrome. [europepmc]
- Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells. [europepmc]
- The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review. [europepmc]
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function. [europepmc]
- GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data. [europepmc]
- Friend and foe: β-cell Ca 2+ signaling and the development of diabetes. [europepmc]
- Diabetes Mellitus and Cardiovascular Disease. [europepmc]
- Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial. [europepmc]
- GLP-1: Molecular mechanisms and outcomes of a complex signaling system. [europepmc]
- Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity. [europepmc]
- Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics. [europepmc]
- Integrating the inputs that shape pancreatic islet hormone release. [europepmc]
- HIF-1α as a Mediator of Insulin Resistance, T2DM, and Its Complications: Potential Links With Obstructive Sleep Apnea. [europepmc]
- Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. [europepmc]
- Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes. [europepmc]
- Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation. [europepmc]
- Trends in insulin resistance: insights into mechanisms and therapeutic strategy. [europepmc]
- Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. [europepmc]
Related